Signadori BIO raises €11 million seed round to advance next-generation solid tumour platform Business Wire (Press Release) 15h
Nona biosciences evolves brand to reflect next phase of growth in biotherapeutic innovation PR Newswire (Press Release) 20h
Vir Biotechnology to participate in bank of America securities 2026 healthcare Conference Business Wire (Press Release) 1d
STAT Plus: Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart disease STAT 1d
Cytokinetics shares jump as Phase 3 ACACIA-HCM trial of Aficamten meets dual primary endpoints RTT News 1d
FDA grants rdep designation to opus for opgx-LCA5 Gene Therapy in treating LCA5 retinal disease RTT News 1d